RNPC3 and neoplasm: Compared to the irrelevant‐RNP control, Trunc‐LMP2A‐RNP and FL‐LMP2A‐RNP exhibited comparable inhibitory effects on tumor progression based on the bioluminescence signal by day 23 (Figure 3B–F).